Glycemic Control – Medxy AI

Resveratrol and Type 2 Diabetes: Does the Red Wine Compound Really Control Blood Sugar?

By MedXY 01/11/2026

A rigorous clinical trial reveals that five weeks of resveratrol supplementation does not improve blood sugar, GLP-1 levels, or gastric emptying in patients with type 2 diabetes.

Diabetes & Endocrinology Internal Medicine news

Video Consultations for Insulin Pump-Treated Type 1 Diabetes: Non-Inferior Glycemic Control with Nuanced Patient Outcomes

By MedXY 01/10/2026

A 52-week RCT demonstrates that video consultations achieve comparable Time in Range (TiR) to physical visits for T1D patients on insulin pumps. While the intervention improved HbA1c and treatment satisfaction, it was associated with an inferior impact on patient quality of life.

Cardiology Diabetes & Endocrinology news

Reversing Prediabetes Halves 30-Year Risk of Cardiovascular Death and Heart Failure: New Insights from DPPOS and DaQing

By MedXY 01/07/2026

A landmark post-hoc analysis of the DPPOS and DaQing studies reveals that achieving prediabetes remission reduces the risk of cardiovascular death and heart failure hospitalization by approximately 50% over three decades, highlighting a profound legacy effect of early glycemic normalization.

Diabetes & Endocrinology news

Efficacy and Safety of Tirzepatide Added to Basal Insulin in Chinese Patients with Type 2 Diabetes: Insights from the SURPASS-CN-INS Phase 3 Trial

By MedXY 11/17/2025

This phase 3 study demonstrates that adding tirzepatide to basal insulin significantly improves glycemic control in Chinese patients with type 2 diabetes, with a manageable safety profile.

Diabetes & Endocrinology news

Enhanced Glycemic Control in Type 1 Diabetes Through Systematic Intensive Therapy and Continuous Glucose Monitoring

By MedXY 10/29/2025

Systematic intensive therapy combined with continuous glucose monitoring significantly improves glycemic control in adults with type 1 diabetes not meeting targets, without increasing adverse events.

Diabetes & Endocrinology OB/GYN & Women's Health

Closed-Loop Insulin Delivery in Type 1 Diabetes During Pregnancy: Insights from the CIRCUIT Randomized Clinical Trial and Contemporary Evidence

By MedXY 10/24/2025

The CIRCUIT trial demonstrates that closed-loop insulin delivery significantly improves glycemic control during pregnancy in type 1 diabetes, increasing time in pregnancy-specific glucose range and reducing hypoglycemia risks relative to standard care.

Cardiology Clinical Updates Diabetes & Endocrinology Specialties

Mobile Text Messaging Enhances Glycemic and Blood Pressure Control in Adults with Uncontrolled Type 2 Diabetes

By MedXY 09/10/2025

A randomized trial in China shows that a 12-month mobile message-based intervention modestly improves HbA1c and systolic blood pressure in patients with uncontrolled type 2 diabetes, supporting mHealth strategies to manage cardiovascular risks.

Diabetes & Endocrinology Family Medicine & Nutrition news Specialties

Fruit Juice or Whole Fruit for Breakfast in Type 2 Diabetes? Understanding Blood Sugar Control Challenges

By MedXY 08/25/2025

A recent randomized trial shows that consuming 100% orange juice, whole orange pieces, or a sugar-sweetened beverage with breakfast results in similar acute postprandial glycemic responses in well-controlled type 2 diabetes patients.

Clinical Updates Diabetes & Endocrinology news Specialties

Berberine Ursodeoxycholate (HTD1801): A Promising Oral Therapy for Type 2 Diabetes with Multifaceted Metabolic Benefits

By MedXY 08/24/2025

A phase 2 randomized trial shows berberine ursodeoxycholate (HTD1801) significantly reduces HbA1c and improves liver and cardiometabolic parameters in type 2 diabetes patients inadequately controlled with diet and exercise, with a favorable safety profile.

Clinical Updates Diabetes & Endocrinology Specialties

Berberine and Cinnamon Synergy: A Promising Adjunct Therapy for Improving Glycemic Control and LDL Cholesterol in Type 2 Diabetes

By MedXY 08/24/2025

A 12-week randomized controlled trial demonstrated that supplementation with berberine plus cinnamon significantly lowers fasting blood sugar, HbA1c, and LDL cholesterol in patients with type 2 diabetes, offering potential for improved cardiometabolic risk management.

Diabetes & Endocrinology Pediatrics Specialties

Adjunct-to-Insulin Therapy Using SGLT2 Inhibitors in Youth with Type 1 Diabetes: Clinical Impact and Renal Outcomes

By MedXY 08/21/2025

SGLT2 inhibitors adjunct to insulin improve glycemic control, reduce hyperfiltration, and are generally safe in youth with type 1 diabetes under careful ketone monitoring and DKA risk mitigation.

AI Diabetes & Endocrinology news Specialties

Harnessing Digital Therapeutics to Improve Glycemic Control in Type 2 Diabetes: Insights from the BRIGHT Trial

By MedXY 08/20/2025

The BRIGHT trial evaluates AspyreRx, a digital cognitive behavioral therapy, for enhancing glycemic control in type 2 diabetes patients with residual hyperglycemia on stable medical therapy, focusing on efficacy, safety, and real-world applicability.

Cardiology Diabetes & Endocrinology Family Medicine & Nutrition news Specialties

Sustained Metabolic Benefits of a Remote Ketogenic Nutrition Program in Veterans with Type 2 Diabetes: A 3-Year Observational Study

By MedXY 08/11/2025

A 3-year observational study demonstrates that a remotely delivered ketogenic nutrition program leads to sustained improvements in glycemic control, weight, medication use, and metabolic markers among US veterans with type 2 diabetes.

Diabetes & Endocrinology news Specialties

Anaerobutyricum soehngenii: A New Hope for Glycemic Control

By MedXY 08/11/2025

Anaerobutyricum soehngenii supplementation shows promise in improving glycemic control and cardiovascular health in at-risk adults.

Clinical Updates Diabetes & Endocrinology news Specialties

Once-Weekly Insulin Regimens in Type 2 Diabetes: Comparative Efficacy, Safety, and Clinical Implications from COMBINE 3 and QWINT Trials

By MedXY 08/02/2025

Once-weekly insulin regimens (IcoSema, efsitora alfa) demonstrate non-inferior glycemic control compared to daily injections in type 2 diabetes, with advantages in hypoglycemia risk, weight, and injection burden.

Diabetes & Endocrinology news OB/GYN & Women's Health Specialties

Revolutionizing Diabetes Management in Pregnancy with Hybrid Closed-Loop Technology

By MedXY 07/29/2025

A groundbreaking trial highlights how hybrid closed-loop systems improve glycemic control for pregnant women with type 1 diabetes, offering enhanced maternal and fetal health outcomes.